Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.25492
Abstract: Tumor hypoxia is a well-recognized driver of resistance to traditional cancer therapies such as chemotherapy and radiation therapy. We describe development of a new nanoconstruct composed of gold nanorods (GNRs) conjugated to carbonic anhydrase IX…
read more here.
Keywords:
therapy;
gnr anti;
gold nanorods;
cancer ... See more keywords